Lupin has received tentative approval for the company's ANDA for Topiramate tablets, 25 mg, 50 mg, 100 mg and 200 mg from the US FDA.
Lupin's Topiramate tablets are the AB-rated generic equivalent of Ortho-McNeil's TOPAMAX tablets, indicated for the treatment of seizures. The brand product had annual sales of approximately $ 2.2 billion for the twelve months ended March 2008, based on IMS health sales data.
The company made this announcement during the trading hours today, 30 May 2008.
Lupin's Topiramate tablets are the AB-rated generic equivalent of Ortho-McNeil's TOPAMAX tablets, indicated for the treatment of seizures. The brand product had annual sales of approximately $ 2.2 billion for the twelve months ended March 2008, based on IMS health sales data.
The company made this announcement during the trading hours today, 30 May 2008.
0 comments:
Post a Comment